AVTX vs ETR · P/E 0.0, rev $441.0K vs P/E 28, rev $12.95B
Avalo Therapeutics Inc (AVTX) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the AVTX and ETR stock pages for the full models.
Not investment advice.